This virtual live activity aims to strengthen pulmonologists’ and APPs’ use of eosinophil testing and biomarker-guided biologic selection to individualize guideline-based care for patients with eosinophilic COPD from a national and Rural Midwest & Great Plains US perspective. Learners have the ability to interact with faculty during live Q&A and access to downloadable resources for future use in practice.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Pricing
99% of listed courses are free
156 of 157 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Pediatrics
- General Surgery
- Gynecologic Oncology
- Hematology
- Infectious Disease
- Interventional Cardiology
- Maternal-Fetal Medicine
- Medical Oncology
- Nephrology
- Neurocritical Care
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Gastroenterology
- Pediatric Infectious Diseases
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Microlearning
- Credit · Up to 1 credit
- Commercial Support
-
Available fromNov 13, 2026
-
Last day to claim creditDec 5, 2026 8 weeks left
-
Answers in CME Inc. (AiCME) Breathing New Life Into the Treatment of COPD With Type 2 Biologics: Personalized Strategies for Evidence-Based Action
-
Answers in CME Inc. (AiCME) Demystifying the Evidence for Biologics in COPD: Strategies for Optimized, Patient-Centered Management
-
Answers in CME Inc. (AiCME) COPD Primary Care Playbook: Boosting Diagnosis, Treatment, and Therapy Escalation for Optimal Disease Control
-
National Association for Continuing Education Responding to the Science Biologics in Practice in COPD
-
Medscape, LLC From Biomarkers to Breakthroughs: Turning Points in Biologic-Driven Chronic Obstructive Pulmonary Disease Care
-
PVI, PeerView Institute for Medical Education ECHOing Innovation in COPD: Transforming Patient Care with the Use of Targeted Biologic Therapy
